Previous 10 |
THOROFARE, N.J., Nov. 22, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, today announced that effective at 8:00 a.m. eastern standard time on Monday, November 25, 2019, the ...
Akers Biosciences (NASDAQ: AKER ) has filed a preliminary prospectus for a public offering of Class A & B Units valued up to $7.5M. More news on: Akers Biosciences, Inc., Healthcare stocks news, Read more ...
2019 has been a pretty rough year in the market with benefactors such as tweetstorms from Trump, decreasing global industrial production and manufacturing numbers, and escalating conflicts between the west and the east. Economists believe that 2020 will be the most volatile year in the stock m...
Akers Biosciences (NASDAQ: AKER ): Q2 GAAP EPS of -$0.06. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Continued Progress Toward Positioning the Company for Strategic Alternatives THOROFARE, N.J., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the “Company”), a developer of rapid health information technologies, report...
Akers Biosciences (NASDAQ: AKER ): Q1 operating loss of $0.90M. Cash, restricted cash and marketable securities of $5.23M Press Release More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, ,
Continued Progress Toward Positioning the Company for Strategic Alternatives THOROFARE, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the “Company”), a developer of rapid health information technologies, reporte...
Ongoing Measures to Streamline Operations, Reduce Costs and Position the Company for Strategic Alternatives THOROFARE, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the “Company”), a developer of rapi...
News, Short Squeeze, Breakout and More Instantly...
Akers Biosciences Inc. Company Name:
AKER Stock Symbol:
NASDAQ Market:
FORT WORTH, Texas, April 29, 2021 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) today announced the appointment of Karen Simon and Janet Pasque to its Board of Directors (the “Board”) effective...
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol " MYMD " Upon Closing, the Combined Company will focus on developing and commercializing novel immunotherapy pipeline assets, including its lead molecule MYMD-1 ...
Akers Biosciences, Inc. (NASDAQ: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending health lifespan and treating immune mediated illnesses, has reached an agreement...